Clinical Trials Browser

Phase 2 × Completed × Pleural Effusion, Malignant × Clear all

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant

NCT04749602 2023-03-08

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Phase 2 Completed

26 enrolled

Thoracic

Pleural Effusion, Malignant

NCT00637676 2022-09-02

Tunneled Pleural Catheter in Partially Entrapped Lung

Phase 2 Completed

50 enrolled

Thoracic

Pleural Effusion, Malignant

NCT00126581 2019-08-07

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Phase 2 Completed

188 enrolled 16 charts

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Pleural Effusion, Malignant

NCT02054052 2019-03-29

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Phase 2 Completed

22 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Pericardial Effusion, Pleural Effusion, Malignant

NCT03394105 2019-03-08

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

Phase 2 Completed

4 enrolled

Thoracic

Pleural Effusion, Malignant

NCT00408460 2017-04-25

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

34 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00215930 2017-03-23

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

53 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00508144 2017-02-13

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Phase 2 Completed

64 enrolled 5 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pericardial Effusion, Pleural Effusion, Malignant

NCT00564733 2017-02-10

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Phase 2 Completed

55 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT01327235 2014-08-01

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Phase 2 Completed

336 enrolled

Thoracic

Pleural Effusion, Malignant

NCT00118183 2013-06-04

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

62 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Clinical Trials

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Tunneled Pleural Catheter in Partially Entrapped Lung

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer